Medtech SMEs Set Out Regulatory Needs As UK Advances Post-EU System

UK regulatory update: February 2023, part II

While the UK continues to develop the future medtech regulatory system for Great Britain, a new market access report recommends how the MHRA should simplify regulatory processes for SMEs.

Shutterstock

The possible recognition of devices approved in trusted global markets is a major item on the medtech agenda of the UK as it develops its standalone system.

The Medicines and Healthcare products Regulatory Agency (MHRA) is an official observer of the Medical Device Single Audit Program (MDSAP)....

More from United Kingdom

More from Europe